hydroxyurea (Hydrea, Droxia) (cont.)

Pharmacy Author:
Medical and Pharmacy Editor:

In-addition to treating cancer, Droxia another oral form of hydroxyurea is used in the management of sickle cell disease. The exact mechanism by which hydroxyurea works to treat sickle cell disease is not understood. The FDA approved hydroxyurea in December 1967.

PRESCRIBED FOR: Hydroxyurea is used to treat several types of cancer including chronic myelogenous leukemia (CML), acute myelogenous leukemia (AML), head and neck cancer, malignant melanoma, ovarian cancer, and polycythemia vera (a disorder of the bone marrow).

Additionally, Droxia (hydroxyurea 200 mg, 300 mg, and 400 mg capsules) is used to reduce the reoccurrence of painful crises and the need for blood transfusions in certain adult patients with sickle cell anemia.

In some cases, hydroxyurea may also be used to treat psoriasis.

SIDE EFFECTS: Known side effects include:

Medically Reviewed by a Doctor on 6/9/2015

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Pill Finder Tool

Need help identifying pills and medications?
Use the pill identifier tool on RxList.

Back to Medications Index